R. Govindan, Mutation Analysis, Others, I PASS, Journal of Clinical Oncology, vol.28, issue.5, pp.713-715
DOI : 10.1200/JCO.2009.25.1637

A. Gazdar, Signaling in Lung Cancer, New England Journal of Medicine, vol.361, issue.10, pp.1018-1020, 2009.
DOI : 10.1056/NEJMe0905763

A. Gazdar, Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors, Oncogene, vol.19, pp.24-31, 2009.
DOI : 10.1016/j.cell.2006.05.013

W. Pao and M. Ladanyi, Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal Method, Clinical Cancer Research, vol.13, issue.17, pp.4954-4955, 2007.
DOI : 10.1158/1078-0432.CCR-07-1387

M. Ronaghi, M. Uhlen, and P. Nyren, DNA SEQUENCING:A Sequencing Method Based on Real-Time Pyrophosphate, Science, vol.281, issue.5375, pp.363-365, 1998.
DOI : 10.1126/science.281.5375.363

S. Dufort, M. Richard, and F. De-fraipont, Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues, Analytical Biochemistry, vol.391, issue.2, pp.166-168, 2009.
DOI : 10.1016/j.ab.2009.05.027

M. Beau-faller, A. Degeorges, E. Rolland, M. Mounawar, M. Antoine et al., Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma [ERMETIC] Project???Part 1), Journal of Thoracic Oncology, vol.6, issue.6, 2011.
DOI : 10.1097/JTO.0b013e318211dcee

W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi et al., EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib, Proceedings of the National Academy of Sciences, vol.101, issue.36, pp.13306-13311, 2004.
DOI : 10.1073/pnas.0405220101

D. Guo, Y. Qi, R. He, P. Gupta, and D. Milewicz, High throughput detection of small genomic insertions or deletions by Pyrosequencing, Biotechnology Letters, vol.25, issue.20, pp.1703-1707, 2003.
DOI : 10.1023/A:1026090218031

M. Kusumoto, S. Yamamoto, T. Yoshida, and T. Tamura, Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer, Clin Cancer Res, vol.14, pp.4751-4757, 2008.

T. Takano, Y. Ohe, H. Sakamoto, K. Tsuta, Y. Matsuno et al., Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.28, pp.6829-6837, 2005.
DOI : 10.1200/JCO.2005.01.0793

J. Gandhi, J. Zhang, Y. Xie, J. Soh, H. Shigematsu et al., Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines, PLoS ONE, vol.13, issue.2, p.4576, 2009.
DOI : 10.1371/journal.pone.0004576.s007

A. Pircher, F. Ploner, H. Popper, and W. Hilbe, Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients, Lung Cancer, vol.69, issue.3, pp.265-271
DOI : 10.1016/j.lungcan.2010.01.017

G. Riely, J. Marks, and W. Pao, KRAS Mutations in Non-Small Cell Lung Cancer, Proceedings of the American Thoracic Society, vol.6, issue.2, pp.201-205, 2009.
DOI : 10.1513/pats.200809-107LC

P. Roberts, T. Stinchcombe, C. Der, and M. Socinski, a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor???Targeted Therapy?, Journal of Clinical Oncology, vol.28, issue.31, 2011.
DOI : 10.1200/JCO.2009.27.4365

T. Tanaka, M. Matsuoka, A. Sutani, A. Gemma, M. Maemondo et al., Frequency of and variables associated with the EGFR mutation and its subtypes, International Journal of Cancer, vol.31, issue.3, pp.651-655
DOI : 10.1002/ijc.24746

K. Masago, S. Fujita, T. Mio, M. Ichikawa, K. Sakuma et al., Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients, International Journal of Clinical Oncology, vol.97, issue.5, pp.442-446, 2008.
DOI : 10.1007/s10147-008-0772-4

Y. Nagai, H. Miyazawa, . Huqun, T. Tanaka, K. Udagawa et al., Genetic Heterogeneity of the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cell Lines Revealed by a Rapid and Sensitive Detection System, the Peptide Nucleic Acid-Locked Nucleic Acid PCR Clamp, Cancer Research, vol.65, issue.16, pp.7276-7282, 2005.
DOI : 10.1158/0008-5472.CAN-05-0331

T. Tanaka, Y. Nagai, H. Miyazawa, N. Koyama, S. Matsuoka et al., Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers, Cancer Science, vol.8, issue.2, pp.246-252, 2007.
DOI : 10.1371/journal.pmed.0020073

H. Kimura, K. Kasahara, M. Kawaishi, H. Kunitoh, T. Tamura et al., Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non-Small-Cell Lung Cancer, Clinical Cancer Research, vol.12, issue.13, pp.3915-3921, 2006.
DOI : 10.1158/1078-0432.CCR-05-2324